CD68+ PD-1+ TAMs in ESCC TME tend to be of M2 phenotype, which can result in the upregulation of PD-L1 expression in tumor cells and promote ESCC invasion and migration (51, 52). This evidence concerns the gene PDCD1 and neoplasm.